Take a look at some of Monday's morning movers:
Amylin Pharmaceuticals - Bristol-Myers Squibb is buying Amylin for $31 per share, or $5.3 billion in cash. In a follow-on deal, AstraZeneca will pay Bristol-Myers $3.4 billion for the right to collaborate on developing Amylin drugs after the deal is complete.
Lincare Holdings - Lincare is being bought by Germany’s Linde for $4.6 billion in cash. Lincare is a specialist in home-based oxygen therapy, while Linde is a maker of industrial gases.
Ingram Micro - The technology distributor is buying wireless device company BrightPoint for $650 million in cash. Ingram is seeking to expand into the mobile market, which has higher profit margins than its core personal computer business.
Barclays - Chairman Marcus Agius has resigned, in the wake of the Libor probe into interest-rate fixing that resulted in Barclays paying more than $450 million in fines. Chief Executive Officer Bob Diamond is also said to be under pressure to resign, but has not done so.
Apple - The company is paying $60 million to China’s ProView Technology to settle a trademark dispute over the iPad name.
Dell - The Wall Street Journal says Dell may announce a deal as soon as today to buy Quest Software, following a back-and-forth bidding contest with private-equity firm Insight Venture Partners. Dell’s most recent offer had been worth $27.50 per share, or about $2.3 billion.
GlaxoSmithKline - The company's experimental once-daily lung drug showed positive results in a late stage clinical trial. The treatment is used for patients suffering from chronic obstructive pulmonary disease, or COPD.
Dish Network - The satellite TV service has removed AMC from its offerings, following the expiration of the contract between the two. Dish says it dropped AMC because it was charging fees that were too high for a low-related channel. AMC countered by pointing out that its show “The Walking Dead” is the highest-rated scripted drama on cable, and that Dish has refused to discuss rates.
United Parcel Service - Deutsche Bank has downgraded UPS shares to "hold" from "buy," saying the stock is valued at a premium relative to its peers, and that accelerating uncertainty in Europe represents a potential headwind.
Micron Technology - The chipmaker will buy bankrupt Japanese Chipmaker Elpida Memory for $750 million cash. It will also pay Elpida's creditors about $1.75 billion in annual installments through 2019.
Lincoln National - Barclays has downgraded the insurance company's stock to "equalweight" from "overweight."
OpenTable - Barclays has cut its rating on the online reservation company's stock to "equalweight" from "overweight."
—By CNBC’s Peter Schacknow
Questions? Comments? Email us at firstname.lastname@example.org